BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29359612)

  • 1. A factor analytic investigation of the Mercy Evaluation of Multiple Sclerosis.
    Merz ZC; Wright JD; Vander Wal JS; Gfeller JD
    Clin Neuropsychol; 2018 Nov; 32(8):1431-1453. PubMed ID: 29359612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of the Verbal Concept Attainment Test in multiple sclerosis.
    Mulligan R; Basso MR; Lau L; Reynolds B; Whiteside DM; Combs D; Bornstein RA
    J Clin Exp Neuropsychol; 2019 May; 41(4):331-340. PubMed ID: 30642223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary investigation of cognitive function in aged multiple sclerosis patients: Challenges in detecting comorbid Alzheimer's disease.
    Roy S; Drake A; Snyder S; Cline B; Khan A; Fuchs T; Zivadinov R; Weinstock-Guttman B; Szigeti K; Benedict RHB
    Mult Scler Relat Disord; 2018 May; 22():52-56. PubMed ID: 29574353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
    Wuerfel E; Weddige A; Hagmayer Y; Jacob R; Wedekind L; Stark W; Gärtner J
    PLoS One; 2018; 13(3):e0194873. PubMed ID: 29566099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test).
    Meca-Lallana JE; Prieto-González JM; Jimenez-Veiga J; Carreón-Guarnizo E; Jiménez-Martín I; Hernández-Clares R; Sistiaga-Berrondo A; Carles-Dies R; García-Molina E; Cerdán-Sánchez M; Costa-Arpín E; Croitoru I; Castillo-Triviño T; Iniesta-Martinez F; García-Pérez E; Olascoaga-Urtaza J
    Mult Scler Relat Disord; 2019 Feb; 28():50-56. PubMed ID: 30553169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Neuronorma battery for neuropsychological assessment in multiple sclerosis.
    Matías-Guiu JA; Sánchez-Benavides G; Rivera-Àvila N; Cortés-Martínez A; Delgado-Alonso C; Delgado-Álvarez A; Montero P; Pytel V; Matías-Guiu J; Peña-Casanova J
    Mult Scler Relat Disord; 2020 Jul; 42():102070. PubMed ID: 32330845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
    Gromisch ES; Zemon V; Holtzer R; Chiaravalloti ND; DeLuca J; Beier M; Farrell E; Snyder S; Schairer LC; Glukhovsky L; Botvinick J; Sloan J; Picone MA; Kim S; Foley FW
    Clin Neuropsychol; 2016 Oct; 30(7):1032-49. PubMed ID: 27279357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations for interpreting failure on individual subtests of the Montreal Cognitive Assessment.
    Moafmashhadi P; Koski L
    J Geriatr Psychiatry Neurol; 2013 Mar; 26(1):19-28. PubMed ID: 23385364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding heterogeneity in older adults: Latent growth curve modeling of cognitive functioning.
    MacAulay RK; Calamia MR; Cohen AS; Daigle K; Foil H; Brouillette R; Bruce-Keller AJ; Keller JN
    J Clin Exp Neuropsychol; 2018 Apr; 40(3):292-302. PubMed ID: 28669314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and reliability of the Georgian-language brief international cognitive assessment for multiple sclerosis (BICAMS).
    Botchorishvili N; Shiukashvili N; Mikeladze N; Dzagnidze A; Mikava N; Tighashvili M; Janelidze M
    BMC Neurol; 2021 Jun; 21(1):218. PubMed ID: 34107913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep and Cognitive Function in Multiple Sclerosis.
    Braley TJ; Kratz AL; Kaplish N; Chervin RD
    Sleep; 2016 Aug; 39(8):1525-33. PubMed ID: 27166237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-validation of non-memory-based embedded performance validity tests for detecting invalid performance among patients with and without neurocognitive impairment.
    White DJ; Korinek D; Bernstein MT; Ovsiew GP; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):459-472. PubMed ID: 32397824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between cognitive function and body mass index in multiple sclerosis patients.
    Owji M; Ashraf-Ganjouei A; Sahraian MA; Bidadian M; Ghadiri F; Naser Moghadasi A
    Mult Scler Relat Disord; 2019 Jul; 32():37-40. PubMed ID: 31030017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cognitive functions in patients with multiple sclerosis applying the normative values of the Rao's brief repeatable battery in the Portuguese population.
    Sousa C; Rigueiro-Neves M; Passos AM; Ferreira A; Sá MJ;
    BMC Neurol; 2021 Apr; 21(1):170. PubMed ID: 33882847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking cognitive impairment in multiple sclerosis using the Brain on Track test: a validation study.
    Ruano L; Branco M; Severo M; Sousa A; Castelo J; Araújo I; Pais J; Cerqueira J; Amato MP; Lunet N; Cruz VT
    Neurol Sci; 2020 Jan; 41(1):183-191. PubMed ID: 31631230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining cognitive speed and accuracy dysfunction in youth and young adults with pediatric-onset multiple sclerosis using a computerized neurocognitive battery.
    Barlow-Krelina E; Fabri TL; O'Mahony J; Gur RC; Gur RE; De Somma E; Bolongaita L; Dunn CL; Bacchus M; Yeh EA; Marrie RA; Bar-Or A; Banwell BL; Till C
    Neuropsychology; 2021 May; 35(4):388-398. PubMed ID: 34043389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived fatigue and cognitive performance change in multiple sclerosis: Uncovering predictors beyond baseline fatigue.
    Hu M; Muhlert N; Robertson N; Winter M
    Mult Scler Relat Disord; 2019 Jul; 32():46-53. PubMed ID: 31030019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire.
    Benedict RH; Munschauer F; Linn R; Miller C; Murphy E; Foley F; Jacobs L
    Mult Scler; 2003 Feb; 9(1):95-101. PubMed ID: 12617275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
    Niccolai C; Portaccio E; Goretti B; Hakiki B; Giannini M; Pastò L; Righini I; Falautano M; Minacapelli E; Martinelli V; Incerti C; Nocentini U; Fenu G; Cocco E; Marrosu MG; Garofalo E; Ambra FI; Maddestra M; Consalvo M; Viterbo RG; Trojano M; Losignore NA; Zimatore GB; Pietrolongo E; Lugaresi A; Pippolo L; Roscio M; Ghezzi A; Castellano D; Stecchi S; Amato MP
    BMC Neurol; 2015 Oct; 15():204. PubMed ID: 26472052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montreal Cognitive Assessment in a Greek sample of patients with multiple sclerosis: A validation study.
    Konstantopoulos K; Vogazianos P
    Appl Neuropsychol Adult; 2021; 28(1):48-52. PubMed ID: 30939943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.